D. Dubois

发表

Glutamylsulfamoyladenosine and pyroglutamylsulfamoyladenosine are competitive inhibitors of E. coli glutamyl-tRNA synthetase

Louis-Patrick Gagnon, R. Chěnevert, J. Lapointe, 2005, Journal of enzyme inhibition and medicinal chemistry.

Characterization of anti-apolipoprotein A-I monoclonal antibodies and their use in the measurement of apolipoprotein A-I by a two-site enzyme immunoassay.

C. Malmendier, D. Dubois, 1989, Journal of immunological methods.

Comparison of different sandwich enzyme immunoassays for the quantitation of human apolipoproteins A-I and A-II.

F. Cantraine, C. Malmendier, D. Dubois, 1987, Journal of immunological methods.

Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration.

L. de Roy, T. Magot, C. Malmendier, 1989, Atherosclerosis.

Mechanisms of hypocholesterolemia.

C. Malmendier, D. Dubois, J. Lontie, 1991, Advances in experimental medicine and biology.

Kinetics of heterogeneous populations of particles.

C. Delcroix, D. Dubois, J. Lontie, 1991, Advances in experimental medicine and biology.

In vivo metabolism of apolipoproteins A-IV and A-I associated with high density lipoprotein in normolipidemic subjects.

P. Gambert, L. Lagrost, C. Malmendier, 1991, Journal of lipid research.

Alterations in lipoprotein density classes in infantile visceral Leishmaniasis: presence of apolipoprotein SAA

M. Bouma, C. Malmendier, M. Ayrault-Jarrier, 1992, European journal of clinical investigation.

Plasma lipids and apolipoproteins in end-stage liver disease.

H. Bismuth, R. Adam, D. Máthé, 1990, Clinica chimica acta; international journal of clinical chemistry.

Apolipoprotein C-II and C-III metabolism in a kindred of familial hypobetalipoproteinemia.

C. Malmendier, C. Delcroix, D. Dubois, 1991, Metabolism: clinical and experimental.

Plasma lipids, lipoproteins and apolipoproteins in two kindreds of hypobetalipoproteinemia.

C. Sérougne, J. Férézou, D. Máthé, 1990, Atherosclerosis.

Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells.

J. Sculier, C. Malmendier, D. Dubois, 1988, Atherosclerosis.

In vivo metabolism of apolipoproteins C-II and C-III in normal and hypertriglyceridemic subjects.

L. de Roy, T. Magot, C. Malmendier, 1988, Advances in experimental medicine and biology.

Non-competitive enzyme-linked immunosorbent assay for human apolipoprotein SAA or S.

C. Malmendier, D. Dubois, 1988, Journal of immunological methods.

Synthesis of glutaminyl adenylate analogues that are inhibitors of glutaminyl-tRNA synthetase.

R. Chěnevert, J. Lapointe, S. Bernier, 2000, Bioorganic & medicinal chemistry letters.

The zinc-binding site of a class I aminoacyl-tRNA synthetase is a SWIM domain that modulates amino acid binding via the tRNA acceptor arm.

Siddhartha Roy, Sheng-Xiang Lin, R. Banerjee, 2004, European journal of biochemistry.

Hotspots of Large Rare Deletions in the Human Genome

J. Raelson, R. Allard, Hélène Fournier, 2010, PloS one.

An aminoacyl-tRNA synthetase-like protein encoded by the Escherichia coli yadB gene glutamylates specifically tRNAAsp.

R. Giegé, C. Cambillau, H. Becker, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Prevalence of dyslipidemia in liver transplant recipients.

H. Bismuth, R. Adam, D. Máthé, 1992, Transplantation.

ATP binding by glutamyl‐tRNA synthetase is switched to the productive mode by tRNA binding

Shigeyuki Yokoyama, Osamu Nureki, O. Nureki, 2003, The EMBO journal.

A C-truncated glutamyl-tRNA synthetase specific for tRNA(Glu) is stimulated by its free complementary distal domain: mechanistic and evolutionary implications.

J. Lapointe, Sébastien P. Blais, D. Dubois, 2009, Biochemistry.

Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.

L. Alcindor, M. Ayrault-Jarrier, D. Dubois, 1993, Clinical physiology and biochemistry.

The Escherichia coli YadB gene product reveals a novel aminoacyl-tRNA synthetase like activity.

R. Vincentelli, R. Giegé, C. Cambillau, 2004, Journal of molecular biology.

Abnormal lipoprotein and marked hypercholesterolemia as paraneoplastic manifestation of a renal adenocarcinoma.

Y. Carpentier, D. Dubois, J. Lontie, 2001, Atherosclerosis.